🚀 go-pugleaf

Dernières parutions d'articles concernant les microARNs dans le cancer
de la vessie:
Most recent articles on microRNAs in bladder cancer:






miR-200 expression regulates epithelial-to-mesenchymal transition in
bladder cancer cells and reverses resistance to epidermal growth
factor receptor therapy.
Adam L, Zhong M, Choi W, Qi W, Nicoloso M, Arora A, Calin G, Wang H,
Siefker-Radtke A, McConkey D, Bar-Eli M, Dinney C.
Clin Cancer Res. 2009 Aug 15;15(16):5060-72.


Genomic profiling of microRNAs in bladder cancer: miR-129 is
associated with poor outcome and promotes cell death in vitro.
Dyrskjøt L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P,
Ramanathan R, Fristrup N, Jensen JL, Andersen CL, Zieger K, Kauppinen
S, Ulhøi BP, Kjems J, Borre M, Orntoft TF.
Cancer Res. 2009 Jun 1;69(11):4851-60.


Identification of novel microRNA targets based on microRNA signatures
in bladder cancer.
Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, Kawamoto K,
Kawahara K, Toki K, Kawakami K, Nishiyama K, Tsujimoto G, Nakagawa M,
Seki N.
Int J Cancer. 2009 Jul 15;125(2):345-52.


The putative tumor suppressor microRNA-101 modulates the cancer
epigenome by repressing the polycomb group protein EZH2.
Friedman JM, Liang G, Liu CC, Wolff EM, Tsai YC, Ye W, Zhou X, Jones
PA.
Cancer Res. 2009 Mar 15;69(6):2623-9.


MicroRNA-143 as a tumor suppressor for bladder cancer.
Lin T, Dong W, Huang J, Pan Q, Fan X, Zhang C, Huang L.
J Urol. 2009 Mar;181(3):1372-80.














InTextoResearch, Baelen, Liège, Wallonie (Wallonia), Belgique
(Belgium) & Agence Wallonne d’Information Scientifique (AWIS) (Marc
Lacroix, scimedweb@mail.com)